1787MO Updated results from the phase III ALINA study of adjuvant alectinib vs chemotherapy (chemo) in patients (pts) with early-stage ALK non-small cell lung cancer (NSCLC)

R Dziadziuszko, BJ Solomon, Y-L Wu, JS Ahn, M Nishio, DH Lee, J-S Lee, W-Z Zhong, H Horinouchi, W Mao, MJ Hochmair, F de Marinis, MR Migliorino, I Bondarenko, T Xu, A Cardona Gavaldon, A Scalori, VA McNally, AA Higgerson, F Barlesi